- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Good
|
- 10-Q Quarterly report
- 10.1 1999 Stock Option Plan
- 10.2 1999 Nonstatutory Stock Option Plan
- 10.3 1999 Stock Option Plan, As Amended Through February 20, 2003
- 10.4 Form of Stock Option Agreement (Incentive Stock Options)
- 10.5 Form of Stock Option Agreement (Nonstatutory Stock Options)
- 10.6 Form of Stock Option Agreement Under the 1999 Nonstatutory Stock Option Plan
- 10.7 Form of Notice of Grant of Stock Option
- 10.8 Form of Stock Option Agreement
- 10.9 Form of Notice of Grant of Restricted Stock Award
- 10.10 Form of Restricted Stock Agreement
- 31.1 Certification of Principal Executive Officer Pursuant to Rule 13A-14(A)
- 31.2 Certification of Principal Financial Officer Pursuant to Rule 13A-14(A)
- 32.1 Certification by the CEO & CFO of PDL Biopharma, Inc.
EXHIBIT 32.1
CERTIFICATION
Mark McDade, Chief Executive Officer, and Andrew L. Guggenhime, Senior Vice President and Chief Financial Officer, of PDL BioPharma, Inc. (the “Registrant”), each hereby certifies in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based on his knowledge:
(1) the Quarterly Report on Form 10-Q for the quarter ended June 30, 2006 of the Registrant, to which this certification is attached as an exhibit (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
A signed original of this written statement required by Section 906 will be provided to the Securities and Exchange Commission or its staff upon request.
Dated: August 9, 2006
/s/ Mark McDade |
Mark McDade Chief Executive Officer (Principal Executive Officer) |
/s/ Andrew L. Guggenhime |
Andrew L. Guggenhime Senior Vice President and Chief Financial Officer (Principal Financial Officer) |